σ1 receptors and the modulation of opiate analgesics

Sigma Receptors: Chemistry, Cell Biology and Clinical Implications

Volumn , Issue , 2007, Pages 337-350

  Pasternak, Gavril W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 39649093976     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-36514-5_16     Document Type: Chapter

References (32)

1. Payne R, Pasternak GW. Pain. In: Johnston MV, Macdonald RL, Young AB. (Eds.), Principles of drug therapy in neurology, F.A. Davis, Philadelphia, 1992, pp. 268-301.
2. Payne R, Pasternak GW. Pharmacology of pain treatment. In: Johnston, M.V., MacDonald R, Young AB. (Eds.), Contemporay Neurolog Series: Scientific Basis of Neurologic Drug Therapy, Davis, Philadelphia, 1992, pp. 268-301.
3. Paris PL, Komisaruk BR, Watkins LR, Mayer DJ. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science 1983, 219:310-312.
4. Watkins LR, Kinscheck IB, Mayer DJ. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. Science 1984, 224:395-396.
5. Noble F, Derrien M, Roques BP. Modulation of opioid antinociception by CCK at the supraspinal level: Evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain. Br J Pharmacol 1993, 109:1064-1070.
6. Lucas GD, Hoffmann O, Alster P, Wiesenfeld-Hallin Z. Extracellular cholecystokinin levels in the rat spinal cord following chronic morphine exposure: An in vivo microdialysis study. Brain Res 1999, 821:79-86.
7. Devillers JP, Boisserie F, Laulin JP, Larcher A, Simonnet G. Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats. Brain Res 1995, 700:173-181.
8. Harrison, LM, Kastin AJ, Zadina JE. Opiate tolerance and dependence: Receptors, Gproteins, and antiopiates. Peptides 1998, 19:1603-1630.
9. Malin DH, Lake JR, Arcangeli KR, Deshotel KD, Hausam DD, Witherspoon WE, Carter VA, Yang H-YT, Pal B, Burgess K. Subcutaneous injection of an analog of neuropeptide FF precipitates morphine abstinence syndrome. Life Sci 1993, 53:PL261-PL266.
10. Chien C-C, Pasternak GW. Functional antagonism of morphine analgesia by (+)- pentazocine: Evidence for an anti-opioid ai system. Eur J Pharmacol 1993, 250:R7-R8.
11. Pasternak GW. Anti-opioid activity of a, systems. Regul Pept 1994, 54:219-220.
12. Chien CC, Pasternak GW. Selective antagonism of opioid analgesia by a σ system. J Pharmacol Exp Ther 1994, 271:1583-1590.
13. Chien CC, Pasternak GW. Sigma antagonists potentiate opioid analgesia in rats. NeurosciLett 1995, 190:137-139.
14. Chien CC, Pasternak GW. (-)-Pentazocine analgesia in mice: Interactions with a a receptor system. Eur J Pharmacol 1995, 294:303-308.
15. Ryan-Moro J, Chien C-C, Standifer KM, Pasternak GW. Sigma1 binding in a human neuroblastoma cell line. Neurochem Res 1996, 21:1309-1314.
16. 1 receptor. Eur J Pharmacol 1997, 331:R5-R7.
17. 1 receptor ligand. Eur J Pharmacol 1997, 321:361-368.
18. 1 receptor. J Neurochem 1998, 70:2279-2285.
19. 1 receptor. Biochem Pharmacol 2001, 62 349-355.
20. Mei JF, Pasternak GW. Sigmai receptor modulation of opioid analgesia in the mouse. J Pharmacol Exp Ther 2002, 300:1070-1074.
21. 1-binding site. Proc Natl Acad Sci USA 1996, 93:8072-8077.
22. Kekuda R, Prasad PD, Fei Y-J, Leibach FH, Ganapathy V, Fei YJ. Cloning and functional expression of the human type 1 σ receptor (hσRl). Biochem Biophys Res Commun 1996, 229:553-558.
23. Seth P, Leibach FH, Ganapathy V. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 σ receptor. Biochem Biophys Res Commun 1997, 241:535-540.
24. Garza HH Jr, Mayo S, Bowen WD, DeCosta BR, Carr DJJ. Characterization of a (+)-azidophenazocine-sensitive σ receptor on splenic lymphocytes. J Immunol 1993, 151:4672-4680.
25. John CS, Bowen WD, Varma VM, McAfee JG, Moody TW. sigma receptors are expressed in human non-small cell lung carcinoma. Life Sci 1995, 56:2385-2392.
26. Kushner L, Zukin SR, Zukin RS. Characterization of opioid, δ, and phencyclidine receptors in the neuroblastoma-brain hybrid cell line NCB-20. Mol Pharmacol 1988, 34:689-694.
27. 3H]3-PPP. Eur J Pharmacol 1986, 124:183-187.
28. Rooney KF, Sewell RD. Evaluation of selective actions of dopamine D-1 and D-2 receptor agonists and antagonists on opioid antinociception. Eur J Pharmacol 1989, 168:329-336.
29. Michael-Titus A, Bousselmame R, Costentin J. Stimulation of dopamine D2 receptors induces an analgesia involving an opioidergic but non enkephalinergic link. Eur J Pharmacol 1990, 187:201-207.
30. Noble F, Cox BM. The role of dopaminergic systems in opioid receptor desensitization in nucleus accumbens and caudate putamen of rat after chronic morphine treatment. J Pharmacol Exp Ther 1997, 283:557-565.
31. Unterwald EM, Cuntapay M. Dopamine-opioid interactions in the rat striatum: A modulatory role for dopamine Dj receptors in δ opioid receptor-mediated signal transduction. Neuropharmacology 2000, 39:372-381.
32. King MA, Bradshaw S, Chang AH, Pintar JE, Pasternak GW. Potentiation of opioid analgesia in dopamine2 receptor knockout mice: Evidence for a tonically active antiopioid system. J Neurosci 2001, 21:7788-7792.